REGENERX BIOPHARMACEUTICALS CO (RGRX)
Institutional ownership reported to the SEC as of Q3 2023, across 20 quarters.
1
Reporting holders
$170
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Williams Jones Wealth Management, LLC. | $170 | 10,000 | 0.00% | 17q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2023 | 1 | $170 | 10,000 | 0 | 0 | 0 | 0.0% |
| Q2 2023 | 1 | $266 | 10,000 | 0 | 0 | 0 | 0.0% |
| Q1 2023 | 1 | $1.1K | 10,000 | 0 | 0 | 0 | 0.0% |
| Q4 2022 | 1 | $1.4K | 10,000 | 0 | 0 | 0 | 0.0% |
| Q3 2022 | 1 | $1.0K | 10,000 | 0 | 0 | 0 | 0.0% |
| Q2 2022 | 2 | $5.0K | 30,000 | 1 | 0 | 0 | 0.0% |
| Q1 2022 | 1 | $2.0K | 10,000 | 0 | 0 | 1 | 0.0% |
| Q4 2021 | 1 | $34.0K | 210,000 | 0 | 0 | 0 | 0.0% |
| Q3 2021 | 1 | $35.0K | 210,000 | 0 | 0 | 0 | 0.0% |
| Q2 2021 | 1 | $57.0K | 210,000 | 0 | 0 | 0 | 0.0% |
| Q1 2021 | 1 | $53.0K | 210,000 | 0 | 0 | 0 | 0.0% |
| Q4 2020 | 2 | $103.0K | 232,300 | 0 | 1 | 0 | 0.0% |
| Q3 2020 | 2 | $89.0K | 222,300 | 0 | 0 | 0 | 0.0% |
| Q2 2020 | 2 | $70.0K | 222,300 | 0 | 0 | 0 | 0.0% |
| Q1 2020 | 4 | $48.0K | 250,740 | 2 | 0 | 0 | 0.0% |
| Q4 2019 | 2 | $31.0K | 222,300 | 0 | 1 | 0 | 0.0% |
| Q3 2019 | 2 | $25.0K | 162,300 | 0 | 0 | 0 | 0.0% |
| Q2 2019 | 3 | $31.0K | 172,300 | 0 | 0 | 1 | 0.0% |
| Q1 2019 | 4 | $749.0K | 184,021 | 0 | 0 | 1 | 0.0% |
| Q4 2018 | 5 | $67.0K | 432,340 | 0 | 0 | 0 | 0.0% |